Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin’s lymphoma

Dendritic cells pulsed with hsp70-peptide complexes derived from human hepatocellular carcinoma induce specific anti-tumor immune responses

Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate

B cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cells

B-cell lymphoma and myeloma protection induced by idiotype vaccination with dendritic cells is mediated entirely by T cells in mice

Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial

Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia

[Current status of hyperthermia for therapy of brain tumor]

Immune-related effects of local hyperthermia in patients with primary liver cancer